Programmed Death-Ligand 1 (PD-L1) Metabolic Modulation Provides Mechanistic and Therapeutic Insight

被引：0
|
作者：
Palermo, A. [1 ]
Spangenberg, S. [2 ]
Guijas, C. [1 ]
Lairson, L. [2 ]
Siuzdak, G. [1 ,3 ]
机构：
[1] Scripps Res Inst, Scripps Ctr Metabol & Mass Spectrometry, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Dept Mol & Computat Biol, La Jolla, CA 92037 USA
来源：
MOLECULAR BIOLOGY OF THE CELL | 2018年 / 29卷 / 26期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P1343
引用
收藏
页码：267 / 267
页数：1
相关论文
共 50 条
  • [21] Programmed Death-Ligand 1 (PD-L1) Expression in Upper Tract Urothelial Carcinoma
    Skala, Stephanie
    Liu, Tzu-Ying
    Udager, Aaron M.
    Weizer, Alon Z.
    Montgomery, Jeffrey S.
    Palapattu, Ganesh S.
    Siddiqui, Javed
    Cao, Xuhong
    Fields, Kristina
    Abugharib, Ahmed E.
    Soliman, Moaaz
    Hafez, Khaled S.
    Miller, David
    Lee, Cheryl T.
    Alva, Ajjai
    Chinnaiyan, Arul M.
    Morgan, Todd M.
    Spratt, Daniel E.
    Jiang, Hui
    Mehra, Rohit
    MODERN PATHOLOGY, 2017, 30 : 260A - 260A
  • [22] Expression of programmed death-ligand 1 (PD-L1) in human pituitary neuroendocrine tumor
    Valentine Suteau
    Alexandre Collin
    Philippe Menei
    Patrice Rodien
    Marie-Christine Rousselet
    Claire Briet
    Cancer Immunology, Immunotherapy, 2020, 69 : 2053 - 2061
  • [23] Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expressions in type 2 endometrial cancer
    Gulec, Umran Kucukgoz
    Bagir, Emine Kilic
    Paydas, Semra
    Guzel, Ahmet Baris
    Gumurdulu, Derya
    Vardar, Mehmet Ali
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2019, 300 (02) : 377 - 382
  • [24] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN TYPE 2 ENDOMETRIAL CANCER
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Seydaoglu, G.
    Guzel, A. B.
    Vardar, M. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 220 - 220
  • [25] Programmed death-ligand 1 (PD-L1) expression in small bowel adenocarcinomas (SBA)
    Pedersen, Katrina
    Smyrk, Thomas C.
    Harrington, Susan
    McWilliams, Robert R.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [26] Programmed Death-Ligand 1 (PD-L1) Expression in Upper Tract Urothelial Carcinoma
    Skala, Stephanie
    Liu, Tzu-Ying
    MUdager, Aaron
    Weizei, Alon Z.
    Montgomery, Jeffrey S.
    Palapattu, Ganesh S.
    Siddiqui, Javed
    Cao, Xuhong
    Fields, Kristina
    Abugharib, Ahmed E.
    Soliman, Moaaz
    Hafez, Khaled S.
    Miller, David
    Lee, Cheryl T.
    Alva, Ajjai
    Chinnaiyan, Arul M.
    Morgan, Todd M.
    Sprott, Daniel E.
    Jiang, Hui
    Mehra, Rohit
    LABORATORY INVESTIGATION, 2017, 97 : 260A - 260A
  • [27] Pan-cancer analysis of programmed death-ligand 1 (PD-L1) amplifications
    Budczies, Jan
    Bockmayr, Michael
    Klauschen, Frederick
    Weichert, Wilko
    Denkert, Carsten
    Stenzinger, Albrecht
    CANCER RESEARCH, 2016, 76
  • [28] Expression of programmed death-ligand 1 (PD-L1) in human pituitary neuroendocrine tumor
    Suteau, Valentine
    Collin, Alexandre
    Menei, Philippe
    Rodien, Patrice
    Rousselet, Marie-Christine
    Briet, Claire
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (10) : 2053 - 2061
  • [29] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN UTERINE GRADE 3 ENDOMETRIOID ADENOCANCER
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Guzel, A. B.
    Khatib, G.
    Seydaoglu, G.
    Vardar, M. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1126 - 1126
  • [30] Assessment of programmed death-ligand 1 (PD-L1) expression in different breast tumor subtypes
    Sobral-Leite, M.
    de Vijver, K. Van
    Kersten, K.
    Peters, D.
    Kok, M.
    Broeks, A.
    De Visser, K. E.
    Schmidt, M. K.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S128 - S128
12345